NCT00775372View on ClinicalTrials.gov

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy
Interventions
DRUG

Clarithromycin 250mg/5mL

Trial Locations (1)

Unknown

Ranbaxy Research Laboratories, Gurgaon

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00775372 - Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions | Biotech Hunter | Biotech Hunter